1. Volume 367, Issue 9517, Pages 1145-1154 (April 2006)
Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial 
Prof L Poston, PhD, AL Briley, MSc, PT Seed, MSc, Prof FJ Kelly, PhD, Prof AH Shennan, FRCOG 
The Lancet 
Volume 367, Issue 9517, Pages (April 2006)
DOI: /S (06)68433-X
Copyright © 2006 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
The Lancet  , DOI: ( /S (06)68433-X)
Copyright © 2006 Elsevier Ltd Terms and Conditions

3. Figure 2
Main neonatal outcomes, according to mother's risk of pre-eclampsia at baseline
*Odds ratios presented for low birthweight because of non-convergence of risk ratios.
The Lancet  , DOI: ( /S (06)68433-X)
Copyright © 2006 Elsevier Ltd Terms and Conditions

4. Figure 3
Plasma concentrations of vitamin C and vitamin E by weeks' gestation
Numbers under each set of data points are numbers of women in treatment (V) and placebo (P) groups who did not develop pre-eclampsia/number of women who did. Bars=SE. *p=0·043 comparing vitamin C in the placebo group between women developing and not developing pre-eclampsia between 20 and 36 weeks' gestation.
The Lancet  , DOI: ( /S (06)68433-X)
Copyright © 2006 Elsevier Ltd Terms and Conditions